IRIS Accounts Production v25.1.4.42 03891210 director 1.1.24 31.12.24 31.12.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh038912102023-12-31038912102024-12-31038912102024-01-012024-12-31038912102022-12-31038912102023-01-012023-12-31038912102023-12-3103891210ns15:EnglandWales2024-01-012024-12-3103891210ns14:PoundSterling2024-01-012024-12-3103891210ns10:Director12024-01-012024-12-3103891210ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3103891210ns10:SmallEntities2024-01-012024-12-3103891210ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3103891210ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3103891210ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3103891210ns10:FullAccounts2024-01-012024-12-3103891210ns10:OrdinaryShareClass12024-01-012024-12-3103891210ns10:CompanySecretary12024-01-012024-12-3103891210ns10:RegisteredOffice2024-01-012024-12-3103891210ns5:CurrentFinancialInstruments2024-12-3103891210ns5:CurrentFinancialInstruments2023-12-3103891210ns5:ShareCapital2024-12-3103891210ns5:ShareCapital2023-12-3103891210ns5:RetainedEarningsAccumulatedLosses2024-12-3103891210ns5:RetainedEarningsAccumulatedLosses2023-12-3103891210ns5:MotorVehicles2024-01-012024-12-3103891210ns5:ComputerEquipment2024-01-012024-12-3103891210ns5:MotorVehicles2023-12-3103891210ns5:ComputerEquipment2023-12-3103891210ns5:MotorVehicles2024-12-3103891210ns5:ComputerEquipment2024-12-3103891210ns5:MotorVehicles2023-12-3103891210ns5:ComputerEquipment2023-12-3103891210ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3103891210ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3103891210ns10:OrdinaryShareClass12024-12-31038912101ns10:Director12023-12-31038912101ns10:Director12022-12-31038912101ns10:Director12024-01-012024-12-31038912101ns10:Director12023-01-012023-12-31038912101ns10:Director12024-12-31038912101ns10:Director12023-12-31
REGISTERED NUMBER: 03891210 (England and Wales)














Unaudited Financial Statements

for the Year Ended 31 December 2024

for

APK CARDIAC SERVICES LIMITED

APK CARDIAC SERVICES LIMITED (REGISTERED NUMBER: 03891210)

Contents of the Financial Statements
for the year ended 31 December 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


APK CARDIAC SERVICES LIMITED

Company Information
for the year ended 31 December 2024







Director: Dr P A Kelly





Secretary: Mrs A M Kelly





Registered office: 69 Chalkwell Esplanade
Westcliff on Sea
Essex
SS0 8JH





Registered number: 03891210 (England and Wales)





Accountants: Cooper Parry Advisory Limited
New Derwent House
69-73 Theobalds Road
London
WC1X 8TA

APK CARDIAC SERVICES LIMITED (REGISTERED NUMBER: 03891210)

Balance Sheet
31 December 2024

2024 2023
Notes £ £ £ £
Fixed assets
Tangible assets 4 49,344 956

Current assets
Debtors 5 1,431,888 1,503,721
Cash at bank 189,774 163,666
1,621,662 1,667,387
Creditors
Amounts falling due within one year 6 17,402 44,204
Net current assets 1,604,260 1,623,183
Total assets less current liabilities 1,653,604 1,624,139

Capital and reserves
Called up share capital 7 100 100
Retained earnings 1,653,504 1,624,039
Shareholders' funds 1,653,604 1,624,139

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 13 August 2025 and were signed by:





Dr P A Kelly - Director


APK CARDIAC SERVICES LIMITED (REGISTERED NUMBER: 03891210)

Notes to the Financial Statements
for the year ended 31 December 2024


1. Statutory information

APK Cardiac Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Motor vehicles - 20% on cost
Office equipment - 25% on reducing balance

Financial instruments
Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


APK CARDIAC SERVICES LIMITED (REGISTERED NUMBER: 03891210)

Notes to the Financial Statements - continued
for the year ended 31 December 2024


2. Accounting policies - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. Employees and directors

The average number of employees during the year was 2 (2023 - 2 ) .

4. Tangible fixed assets
Motor Office
vehicles equipment Totals
£ £ £
Cost
At 1 January 2024 - 5,161 5,161
Additions 60,784 - 60,784
At 31 December 2024 60,784 5,161 65,945
Depreciation
At 1 January 2024 - 4,205 4,205
Charge for year 12,157 239 12,396
At 31 December 2024 12,157 4,444 16,601
Net book value
At 31 December 2024 48,627 717 49,344
At 31 December 2023 - 956 956

5. Debtors: amounts falling due within one year
2024 2023
£ £
Trade debtors 2,669 3,792
Other debtors 1,429,219 1,499,929
1,431,888 1,503,721

6. Creditors: amounts falling due within one year
2024 2023
£ £
Taxation and social security 13,568 40,370
Other creditors 3,834 3,834
17,402 44,204

APK CARDIAC SERVICES LIMITED (REGISTERED NUMBER: 03891210)

Notes to the Financial Statements - continued
for the year ended 31 December 2024


7. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £ £
100 Ordinary £1 100 100

8. Director's advances, credits and guarantees

The following advances and credits to a director subsisted during the years ended 31 December 2024 and 31 December 2023:

2024 2023
£ £
Dr P A Kelly
Balance outstanding at start of year 1,210,863 1,254,071
Amounts advanced 142,587 60,927
Amounts repaid (184,552 ) (104,135 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 1,168,898 1,210,863

Interest of 2.5% has been charged on the advance and it is repayable on demand.